UNICHEM LABORATORIES
Back to Balance Sheet
|
UNICHEM LABORATORIES Last 5 Year Total Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Liabilities | ₹3,707 Cr | ₹3,544 Cr | ₹3,268 Cr | ₹3,183 Cr | ₹3,314 Cr |
What is the latest Total Liabilities ratio of UNICHEM LABORATORIES ?
| Year | Total Liabilities |
|---|---|
| Mar2026 | ₹3,707 Cr |
| Mar2025 | ₹3,544 Cr |
| Mar2024 | ₹3,268 Cr |
| Mar2023 | ₹3,183 Cr |
| Mar2022 | ₹3,314 Cr |
How is Total Liabilities of UNICHEM LABORATORIES Trending?
| Years | Total Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹3,707 Cr | 4.61 | |
| Mar2025 | ₹3,544 Cr | 8.43 | |
| Mar2024 | ₹3,268 Cr | 2.68 | |
| Mar2023 | ₹3,183 Cr | -3.97 | |
| Mar2022 | ₹3,314 Cr | - | |
Compare Total Liabilities of peers of UNICHEM LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| UNICHEM LABORATORIES | ₹3,556.3 Cr | -5.5% | 10.9% | -17.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹467,870.0 Cr | 0.8% | 6.3% | 18.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹220,946.0 Cr | 8.6% | 20.7% | 18.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹190,907.0 Cr | 1.7% | 9.4% | 38.5% | Stock Analytics | |
| CIPLA | ₹118,674.0 Cr | 4.5% | 1.2% | -1.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹97,648.7 Cr | -0.3% | -14.8% | -9.5% | Stock Analytics | |
UNICHEM LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| UNICHEM LABORATORIES | -5.5% |
10.9% |
-17.7% |
| SENSEX | 2.4% |
1.5% |
-4.3% |
You may also like the below Video Courses